Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-DE-107917-3   |   PDF   |   Print   |  
| 
published: 24 Mar 2015 last updated: 31 Jul 2020
General Information
6786-01-0213 (adv. 42010.0213); Summary of the risk assessment of a deliberate release (field trial) of genetically modified Rhodococcus equi RG2837, issued by the German Competent Authority
EN
04 Jun 2012
Methodology and points to consider
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
EN
EN
EN
Adverse effects on human or animal health or on the environment are not expected.
EN
EN
EN
One field site in Germany, for details refer to the German LMO/GMO location register (http://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
EN
EN
Additional information
deliberate release, no placing on the market.
animal experiment for vaccine design
publication:
Bargen and Haas (2009) Molecular and infection biology of the horse pathogen Rhodococcus equi, FEMS Microbiol Rev, 33: 870-891
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Risk assessment 1